By Patricia Weiss
FRANKFURT (Reuters) – Generic drugmaker Stada has asked the German government to seek assurances from Ukraine that the company can continue operations there even though it also does business in Russia, according to a letter seen by Reuters.
In the March 21 letter to German Economy Minister Robert Habeck, Stada CEO Peter Goldschmidt said there was a risk Kyiv might withdraw the company’s market authorisation.
Stada “still has no longer-term certainty that we will be able to sell our products in Ukraine in the future,” the letter said, with the subject line: “Please prevent the exclusion of international pharmaceutical companies from the Ukrainian market.”
The Economy Ministry did not have an immediate comment on the letter.
Habeck promised investment guarantees for German companies during a trip to Ukraine on Tuesday as part of his goal to speed up reconstruction in the war-torn country….
Read More
